Llwytho...
Irreversible electroporation and the pancreas: What we know and where we are going?
Pancreatic adenocarcinoma continues to have a poor prognosis with 1 and 5 years survival rates of 27% and 6% respectively. The gold standard of treatment is resection, however, only approximately 10% of patients present with resectable disease. Approximately 40% of patients present with disease that...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | World J Gastrointest Surg |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Baishideng Publishing Group Inc
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4550840/ https://ncbi.nlm.nih.gov/pubmed/26328033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v7.i8.138 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|